I'd like to thank the committee for inviting me to this.
I want to speak about the rise of synthetic drugs in the Canadian drug market and how this has affected the minds and safety of the Canadian population.
How did we get here? In 1958, Arthur Sackler launched the Terramycin campaign and invented direct-to-physician marketing. In 1959, Paul Janssen invented fentanyl. Arthur Sackler and his brothers made so much money from the Terramycin campaign that they bought Purdue pharmaceuticals. In 1980, Porter and Jick wrote a five-line letter to the editor that addiction was rare in people prescribed narcotics. In 1996, James Campbell, president of the American Pain Society, launched the campaign “pain as the fifth vital sign”. In that same year, Purdue pharmaceuticals released OxyContin. They used the direct-to-physician marketing that was invented by Arthur Sackler and cited the five-line letter to the editor by Porter and Jick. This laid the groundwork for a population that had a tolerance for fentanyl. OxyContin became supplanted by fentanyl in 2010.
In 2006 there was a restriction on the sale of Ephedra in Canada. The Mexican cartels responded by perfecting the phenyl-2-propanone method. When they were using the ephedrine method, they would make one molecule of l-methamphetamine and one molecule of d-methamphetamine. L-methamphetamine was a nasal decongestant and d-methamphetamine was psychoactive. With this new method, they had a very potent version of crystal meth. Both of these invaded the Canadian drug market.
When you look at these drugs, they tend to be co-ingested. When you look at the overdoses that occurred in British Columbia in 2021-22, about 70% of the folks who died of overdose that year had stimulants in their system.
By 2017, the most used drug by incarcerated individuals in British Columbia was methamphetamine. Why is this problematic? Well, there's the issue of substance-induced psychosis. Substance-induced psychosis is a neurotoxic event. It means initially people won't get psychotic when using meth. They get psychotic during intoxication, then during withdrawal and then during the sobriety phase. Every time they get psychotic, it's more likely to happen again, it's harder to treat, and it tends to be more severe.
In 2022 Premier David Eby had the Butler-LePard report done. They looked at random stranger violence. They found in that report that three of the main drivers were, one, mental illness; two, acquired brain injuries due to the toxic drug supply; and three, methamphetamine use.
This also affects recidivism. There's a term called “concurrent disorders”, which is when folks have psychiatric and substance use disorders at the same time. Of folks who were incarcerated in British Columbia, 72% who had concurrent disorders were likely to have recidivism during that time, so it was the most important risk factor.
When we look at the population of British Columbia writ large, by 2021 there were about 75,000 people with opioid use disorder. Now, 80% of them had a psychiatric disorder, so concurrent disorders in British Columbia are the rule, not the exception. When we look at folks with opioid use disorder in British Columbia, about 12,000 of them will have a psychotic disorder as well.
I'm not sure if you have been to the Downtown Eastside in Vancouver. There are about 18,000 people there. There was a study called the “The Hotel Study”, in which they found that about 95% of the people in the study had substance use disorders, about three-quarters had a mental illness, 47% had psychosis and 45% had diagnosable neurological disorders. There was a clinical triad of substance use disorders, psychiatric disorders and brain injury.
What do we do about it? Treating addictions is complicated. The opioid crisis has been approached as though there's been an opioid deficiency: If we prescribe more opioids, we'll get out of this. Almost the entire focus has been on giving people enough different kinds of opioids, assuming this will solve the crisis.
Opioid use disorder is not an opioid deficiency. Any place on earth that has treated the opioid crisis used multiple approaches where medication was just a small part. Psychological therapies are not covered. The intervention with the most evidence for amphetamine use disorder is contingency management. We need to look at a wide range of evidence and solutions. It is unlikely we'll find a home run intervention. With the varied population, we'll need input from public health, addiction medicine and addiction psychiatry, among others.
There is Canadian evidence that treating people with mental health and addiction issues concurrently will help keep this population alive. Psychosis increases the risk of violence fourfold, so treating psychosis is important in preventing violence. Early access to treatment for concurrent disorders can help change the trajectory of the illness and the associated risks. Clients, especially high-risk clients, need timely access to treatments. Along with treatments, there needs to be stable housing with appropriate supports. There needs to be vocational rehabilitation opportunities. There's the “approved home” model in British Columbia, which is a service that has two main purposes. One is to provide long-term residence, and the second is to provide secure, low-barrier treatment and recovery. They have severe—
